Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions June 8 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Monday:
** U.S. group Ingredion <INGR.N> has struck a deal to buy Britain's Tate & Lyle <TATE.L> for £2.7 billion ($3.6 billion) in cash to create a leading speciality food and beverage ingredients company.
nL6N42G0CY
** Intesa Sanpaolo <ISP.MI> has taken a 3% stake in Generali <GASI.MI> to prevent the insurer from building a defensive stake in Italy's biggest bank, CEO Carlo Messina told analysts.
nS8N3EV02A
** Italy's biggest banking group Intesa Sanpaolo <ISP.MI> said it has made a €30.6 billion ($35 billion) unsolicited cash-and-share bid to buy smaller rival Monte dei Paschi di Siena (MPS) <BMPS.MI> in Italy's biggest banking deal ever.
nL4N42G0DE
** U.S. biotech Incyte Pharma <INCY.O> is nearing a deal for up to $2 billion to buy blood disorder drug developer Star Therapeutics, the Financial Times reported on Sunday, citing people familiar with the matter.
nL1N42F02C
(Compiled by Rajarshi Roy and Megavarshini G. Somasundaram in Bengaluru)
Recent news on Ingredion
See all newsBrief: Diego Reynoso To Join Ingredion As Chief Financial Officer
Ingredion Inc reports results for the quarter ended June 30 - Earnings Summary
Ingredion Inc beats Q2 sales estimates, reaffirms 2026 guidance
Brief: Ingredion Q2 Adjusted EPS USD 2.82 Vs. IBES Estimate USD 2.72
Brief: Ingredion’S 595 Pence All-Cash Offer To Acquire Tate & Lyle Accepted By Their Shareholders